GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,452,000 | -41.1% | 33,337 | -41.1% | 0.01% | -27.3% |
| Q1 2022 | $2,466,000 | +7.7% | 56,619 | +9.1% | 0.01% | +83.3% |
| Q4 2021 | $2,289,000 | +110.4% | 51,914 | +90.0% | 0.01% | +50.0% |
| Q2 2021 | $1,088,000 | -40.4% | 27,318 | -46.6% | 0.00% | -63.6% |
| Q1 2021 | $1,826,000 | -57.7% | 51,149 | -56.4% | 0.01% | -65.6% |
| Q4 2020 | $4,317,000 | +419.5% | 117,312 | +431.4% | 0.03% | +190.9% |
| Q3 2020 | $831,000 | -35.1% | 22,076 | -34.6% | 0.01% | -66.7% |
| Q1 2020 | $1,280,000 | -70.4% | 33,780 | -63.3% | 0.03% | +26.9% |
| Q4 2019 | $4,328,000 | +816.9% | 92,115 | +733.3% | 0.03% | +550.0% |
| Q3 2019 | $472,000 | -75.5% | 11,054 | -77.1% | 0.00% | -78.9% |
| Q2 2019 | $1,928,000 | -6.0% | 48,175 | -1.9% | 0.02% | -13.6% |
| Q1 2019 | $2,052,000 | – | 49,114 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |